CBD.market Store Adds Top-Rated CBDA and CBG Brands in Response to New Covid Study Findings

  • Published February 8, 2022

CBD.market Store Adds Top-Rated CBDA and CBG Brands in Response to New Covid Study Findings

SAN DIEGO–(BUSINESS WIRE)–Feb 8, 2022–

CBD.market, a leading CBD online store, has gathered the best brands for CBDA and CBG products to make it easier for customers to find the best items with potential therapeutic effects.

CBDA and CBGA have become the subject of recent research on how cannabinoids interact with COVID-19. A study released in January 2022 by the American Chemical Society and American Society of Pharmacognosy indicates that these two cannabinoids have shown promise in blocking the SARS-CoV-2 virus. The study tested the effect of various cannabinoids on pseudovirus with spike proteins on the surface of the virus cells, similar to the spikes exhibited by all the forms of the Coronavirus.

CBDA and CBGA had the highest rates to block infection of human epithelial cells and appear to help block infection of the original COVID-19 virus and several of its variants. After success with the pseudovirus, researchers conducted tests on live Coronaviruses and found that the CBDA and CBGA had the same results. The use of cannabinoids essentially neutralizes the ability of the spike protein to latch onto human cells and infect them.

Cannabigerolic acid (CBGA) is the acidic form of cannabigerol (CBG). Manufacturers extract CBG from the industrial hemp plant and make various CBG products, including oils, capsules, gummies, isolates, and more.